News|Articles|December 4, 2024
ThreoTech LLC settles patent infringement lawsuit on Magtein magnesium L-threonate
Author(s)Sebastian Krawiec
ThreoTech LLC has announced that it has reached a confidential settlement with Green Jeeva to end a patent infringement lawsuit regarding Magtein magnesium L-threonate.
Advertisement
ThreoTech LLC has announced that it has reached a confidential settlement with Green Jeeva to end a patent infringement lawsuit regarding Magtein magnesium L-threonate. The lawsuit was originally filed on August 15, 2024 in the Central District of California.
“Magtein is a unique dietary supplement ingredient protected by a variety of composition and use patents,” said Edward Lee, CEO of ThreoTech, LLC, in a press release. “Our patent portfolio and other intellectual property supporting Magtein magnesium L-threonate is strong. We stand ready to protect our intellectual property.”
ThreoTech LLC is the exclusive licensee of a portfolio of patents owned by Neurocentria Inc. Magtein has been shown in research to support
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Nutritional Outlook - Supplement, Food & Beverage Manufacturing Trends
1
FAQ: How Do Manufacturers Substantiate a Health Claim?
2
Melt-to-Make Launches Prebiotic Fiber Pectin Base as Gut-Health Demand Increases
3
FDA Finalizes Order for Orange B Revocation, Proposes to Remove Citrus Red No. 2
4
All G's LFX Brings Commercial-Scale Apo-Lactoferrin to the US Market
5